Ajanta Pharma has informed pursuant to Regulation 39(3) of SEBI (Listing obligation and Disclosure Requirement) Regulation, 2015 (Listing Regulations) that the company has on 3rd September 2021 issued duplicate share certificate of the shareholder, Pushpadevi R. Agrawal (Folio No: 0000312).
The above information is a part of company’s filings submitted to BSE.